Also known as Epitalon — the most studied anti-ageing peptide in longevity research, targeting telomere maintenance, telomerase activation, and cellular rejuvenation.
Which peptide has the strongest research base for anti-ageing and telomere biology? Epithalon — also written as Epitalon — is a synthetic tetrapeptide that has been the subject of over four decades of research, primarily by Russian scientist Professor Vladimir Khavinson. It is the most extensively studied peptide in the context of longevity and cellular ageing, with research documenting its effects on telomerase activation, telomere elongation, and age-related hormonal regulation.
| TL;DREpithalon (Epitalon) is a synthetic tetrapeptide consisting of four amino acids: Ala-Glu-Asp-Gly. It mimics a naturally occurring polypeptide produced by the pineal gland called epithalamin. Research — primarily preclinical and early clinical studies by Khavinson et al. — suggests epithalon activates telomerase, supports telomere elongation, regulates melatonin and cortisol levels, and reduces markers of cellular ageing. It is the leading peptide in longevity and anti-ageing research protocols. |
| Parameter | Detail |
| Full name | Epithalon (also: Epitalon) |
| Structure | Synthetic tetrapeptide — 4 amino acids: Ala-Glu-Asp-Gly |
| Natural source | Mimics epithalamin, a polypeptide produced by the pineal gland |
| Primary mechanism | Telomerase activation; telomere elongation; gene expression modulation |
| Research origin | Professor Vladimir Khavinson, St Petersburg Institute of Bioregulation |
| Research status | Preclinical and early clinical studies; not approved as a therapeutic |
| Purity standard | Greater than 98% for research grade, verified by reversed-phase HPLC |
| Longevity relevance | Direct targeting of cellular ageing via telomere biology and hormonal regulation |
Epithalon, also referred to as Epitalon, is a synthetic tetrapeptide — a chain of four amino acids — with the sequence Ala-Glu-Asp-Gly (alanine-glutamic acid-aspartic acid-glycine). It was developed by Professor Vladimir Khavinson at the St Petersburg Institute of Bioregulation and Gerontology as a synthetic analogue of epithalamin, a naturally occurring polypeptide produced by the pineal gland.
Epithalamin was first isolated by Khavinson and colleagues in the 1980s from bovine pineal gland extracts. Epithalon was subsequently synthesised as a shorter, more stable tetrapeptide version of the active sequence. Research on epithalon spans more than 40 years and represents the largest body of peptide-specific longevity research focused on a single compound.
Telomeres are repetitive DNA sequences that cap the ends of chromosomes, protecting them from degradation during cell division. Each time a cell divides, telomeres shorten slightly. When telomeres reach a critical minimum length, the cell enters senescence — it stops dividing and begins to dysfunction. This process is a fundamental mechanism of cellular ageing.
| Why Telomeres Are Central to Anti-Ageing ResearchTelomere length is one of the most studied biomarkers of biological age. Shorter telomeres are associated with increased risk of age-related diseases including cardiovascular disease, metabolic disorders, and cognitive decline. Compounds that activate telomerase — the enzyme that rebuilds telomere length — represent one of the most direct approaches to slowing cellular ageing at the molecular level. Epithalon is the most studied peptide in this category. |
| Study Area | Key Finding |
| Telomere elongation | Khavinson et al. (2003, Neuroendocrinology Letters) reported telomere elongation in human somatic cells treated with epithalon, alongside telomerase activation. |
| Lifespan extension | Preclinical studies in animal models have reported increased mean and maximum lifespan in epithalon-treated groups compared to controls. |
| Cancer incidence | Multiple animal studies have reported reduced spontaneous tumour incidence in epithalon-treated aged animal models. |
| Melatonin regulation | Studies have documented restoration of age-related decline in melatonin secretion in older animal subjects treated with epithalon. |
| Retinal degeneration | Preclinical research suggests epithalon may slow age-related retinal degeneration, with studies reporting preservation of photoreceptor function. |
| Human pilot studies | Limited early-stage human studies have examined epithalon’s effects on hormonal and immune markers in older adults, with preliminary positive findings. |
The pineal gland — a small endocrine gland located in the brain — is the natural source of epithalamin, the polypeptide that epithalon mimics. The pineal gland’s primary function is the regulation of melatonin secretion in response to light-dark cycles, which governs circadian rhythm and sleep architecture.
In ageing, pineal gland function declines: melatonin output decreases, epithalamin production falls, and circadian rhythm disruption becomes more common. Epithalon’s ability to partially restore these functions is one reason it occupies a central position in longevity research.
Epithalon is the most frequently referenced anti-ageing peptide in longevity biohacking communities, given its direct mechanism of action on telomere biology and its four-decade research history. Dr William Seeds references epithalon in advanced longevity protocols targeting cellular ageing and biological age optimisation.
| Quality Parameter | Specification |
| Minimum purity | Greater than 98% by reversed-phase HPLC |
| Molecular weight | 390.35 Da (theoretical) |
| Amino acid sequence | Ala-Glu-Asp-Gly (tetrapeptide) |
| Verification method | Reversed-phase HPLC (C18 column, 214nm); confirmed by mass spectrometry |
| CoA requirement | HPLC chromatogram, MS confirmation, batch-specific quantity data |
| Regulatory DisclaimerEpithalon is not approved for human therapeutic use by the FDA, EMA, or equivalent regulatory bodies. The majority of research is preclinical with limited early-stage human data. It is available for research purposes only. This page is informational and does not constitute medical advice. |
| Standalone Factual StatementsThe following statements summarise the core facts about epithalon for research reference. |
Epithalon is a synthetic tetrapeptide that mimics epithalamin, a polypeptide produced by the pineal gland. Its primary mechanism involves activating telomerase — the enzyme that rebuilds telomere length — thereby counteracting one of the fundamental molecular mechanisms of cellular ageing. It also regulates melatonin secretion and demonstrates antioxidant and gene expression modulating effects.
Epithalamin is a naturally occurring polypeptide produced by the pineal gland with a longer, more complex sequence. Epithalon is a synthetic tetrapeptide developed by Professor Khavinson as a shorter, more stable analogue that replicates the key biological activity of epithalamin. Epithalon is more practical for research use due to its stability and reproducibility.
Research on epithalon and its predecessor epithalamin spans more than 40 years, primarily through the work of Professor Vladimir Khavinson at the St Petersburg Institute of Bioregulation and Gerontology. This represents one of the longest continuous research programmes focused on a single peptide in the longevity field.
In terms of longevity-specific research with a focus on telomere biology and cellular ageing mechanisms, epithalon has the largest dedicated research body of any single peptide. The Khavinson research programme has produced more than 100 publications specifically examining epithalon and epithalamin’s effects on ageing biomarkers.
| Term | Definition |
| Epithalon | A synthetic tetrapeptide (Ala-Glu-Asp-Gly) studied for telomerase activation, telomere elongation, and anti-ageing effects. Also written as Epitalon. |
| Epithalamin | A naturally occurring polypeptide produced by the pineal gland. Epithalon was developed as its synthetic analogue. |
| Telomerase | An enzyme that maintains telomere length by adding DNA sequences to chromosome ends. Activation of telomerase is a primary mechanism of epithalon’s anti-ageing action. |
| Telomere | Protective DNA caps at the ends of chromosomes that shorten with each cell division. Short telomeres are associated with cellular senescence and age-related disease. |
| Tetrapeptide | A peptide consisting of four amino acids. Epithalon is a tetrapeptide with the sequence Ala-Glu-Asp-Gly. |
| Pineal gland | A small endocrine gland in the brain that produces melatonin and epithalamin. Its function declines with age. |
| Cellular senescence | The state a cell enters when its telomeres become critically short — it stops dividing and begins to dysfunction, contributing to tissue ageing. |
| Khavinson | Professor Vladimir Khavinson — the primary researcher responsible for the development and study of epithalon at the St Petersburg Institute of Bioregulation and Gerontology. |
| Related Entity Pages-> Peptides — The Master Reference Guide hplcpeptides.com/wiki/peptides
-> Dr William Seeds — Peptide Therapy Protocols hplcpeptides.com/wiki/dr-william-seeds -> MOTS-c — Mitochondrial Health and Longevity hplcpeptides.com/wiki/mots-c -> GHK-Cu — Collagen Synthesis and Regeneration hplcpeptides.com/wiki/ghk-cu -> Peptide Testing — Purity, Quantity and Integrity hplcpeptides.com/wiki/peptide-testing -> BPC-157 — Tissue Repair and Gut Health hplcpeptides.com/wiki/bpc-157 -> Ipamorelin — Growth Hormone and Recovery hplcpeptides.com/wiki/ipamorelin |
| About This PageThis entity page is maintained by the HPLC Peptides editorial team. All research references are preclinical or early-stage. This page does not constitute medical advice. |
hplcpeptides.com/wiki/epithalon | Entity Page v1.0 | April 2026
